Product Code: 978-1-68038-407-9
Smart Healthcare Market Growth & Trends:
The global smart healthcare market size is expected to reach USD 483.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.3% from 2022 to 2030. The COVID-19 pandemic is likely to boost the market growth as these solutions help healthcare professionals to connect effectively with their patients and offer quality treatment. Owing to social distancing, remote patient monitoring, and virtual healthcare delivery is gaining momentum. For instance, the U.K. has introduced free virtual consultation during the coronavirus crisis. In April 2020, doctorinthehouse.net, a not-for-profit online healthcare service in the U.K. launched a platform in collaboration with volunteers amongst doctors, pharmacists, and specialist nurses aiming to schedule 25,000 online appointments and supply 100,000 online assessments for over 200 at-home clinicians. Such initiatives are expected to drive the market ahead.
Operating costs are mainly governed by production costs, inventory storage costs, manufacturing overhead costs, wages, energy costs, and logistical costs. Poor inventory control is a major issue faced by companies that leads to substantial operating losses. There is an increasing demand for RFID kanban systems to control their inventory costs. RFID kanban systems owing to associated benefits such as reduction in manpower, higher efficiency, and cost-effectiveness is anticipated drive traction over the forecast period.
Technological advancements are rapidly transforming the market for smart healthcare. Some of the major market players such as IBM, Cisco, Given Imaging, Inc., Olympus Corporation, Logi-Tag, Brooks Automation, Stanley Innerspace, GE Healthcare, and others account for a substantial market share, owing to their extensive product offerings. Key players are focusing on expanding their current portfolio as in March 2020, Siemens Healthineers launched Teamplay digital health platform. It is aimed to enable digital healthcare transformation and eases quick access to clinical and operational solutions. Also, in June 2019, Intel introduced Network And Custom Logic Group it is a broad portfolio of products for Artificial Intelligence (AI) and 5G cloud. This is aimed to broaden the horizons of healthcare applications.
Smart Healthcare Market Report Highlights:
- The mHealth segment held the dominant share of over 39.0% in 2021 due to the growing usage of the internet, penetration of smartphones, and the increased adoption of mHealth technologies by healthcare professionals and patients
- The telemedicine segment is expected to be the second-fastest-growing segment from 2022 to 2030. The growing prevalence of chronic conditions, rising demand for self-health care, and the outbreak of COVID-19 pandemic are the key factors driving the growth
- The smart pills segment demonstrated promising growth during the forecast period owing to technological development including miniaturization of integrated circuits, an increase in focus on patient convenience, and high demand for minimally invasive procedures
- Companies are adopting innovative strategies to attain a competitive advantage. Product development, partnerships, strategic collaborations, mergers and acquisitions, and regional expansion are a few of them
- Since April 2020, IBM Research has been keenly developing novel cloud and AI-powered technologies that can assist researchers throughout a range of scientific disciplines and accelerate the discovery process
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research Methodology
- 1.2 Information Procurement
- 1.2.1 Purchased Database:
- 1.2.2 Gvr's Internal Database
- 1.2.3 Secondary Sources
- 1.2.4 Primary Research:
- 1.2.5 Details Of Primary Research
- 1.3 Information or Data Analysis
- 1.3.1 Data Analysis Models
- 1.4 Market Formulation & Validation
- 1.5 Model Details
- 1.5.1 Commodity Workflow Analysis (Model 1)
- 1.6 List of Secondary Sources
- 1.7 List of Primary Sources
- 1.8 Abbreviations
- 1.9 Report Objectives
Chapter 2 Executive Summary
Chapter 3. Smart Healthcare Industry Outlook
- 3.1. Market Lineaage Outlook
- 3.1.1 Parent Market
- 3.1.2 Ancillary Market
- 3.2 Smart Healthcare Market Segmentation
- 3.3. Smart Healthcare Market Size and Growth Prospects
- 3.4. Smart Healthcare Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.5. Key Opportunities Prioritized
- 3.6. Industry Analysis - Porter's
- 3.7 Smart Healthcare Market PESTEL Analysis
Chapter 4. Smart Healthcare Market: Covid-19 Impact
- 4.1.Current And Future Impact Analysis
- 4.2 Disease Prevalence Analysis
- 4.3 Opportunity Analysis
- 4.4 Impact On Market Players
Chapter 5. Smart Healthcare Product Outlook
- 5.1. Smart Healthcare Market Share By Product, 2021 & 2030
- 5.2. RFID KanBan Systems
- 5.2.1. RFID Kanban Systems Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.3. RFID Smart Cabinets
- 5.3.1. RFID Smart Cabinets Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.4. Electronic Health Records (EHR)
- 5.4.1. EHR Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.4.2. Client-Server Based Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.4.3. Web-Based Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.5. Telemedicine
- 5.5.1. Telemedicine Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.5.2. Hardware Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.5.3. Connectivity & Network Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.5.4. Others Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.6. mHealth
- 5.6.1. mHealth Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.6.2. Monitoring Services Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.6.3. Diagnosis Services Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.6.4. Healthcare Systems Strengthening Services Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.6.5. Others Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.7. Smart Pills
- 5.7.1. Smart Pills Market Estimates and Forecasts, 2017 - 2030 (USD Million)
- 5.8. Smart Syringes
- 5.8.1. Smart Syringes Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 6. Smart Healthcare Regional Outlook
- 6.1. Smart Healthcare Market Share By Region, 2017 & 2030
- 6.2. North America
- 6.2.1. North America Market Estimates and Forecasts, by Product, 2017 - 2030 (USD Million)
- 6.2.1.1. U.S. Market Estimates and Forecasts
- 6.2.1.2. Canada Market Estimates and Forecasts
- 6.3. Europe
- 6.3.1. Europe Market Estimates and Forecasts, by Product, 2017 - 2030 (USD Million)
- 6.3.1.1. Germany Market Estimates and Forecasts
- 6.3.1.2. U.K. Market Estimates and Forecasts
- 6.3.1.3. Spain Market Estimates and Forecasts
- 6.3.1.4. Italy Market Estimates and Forecasts
- 6.3.1.5. France Market Estimates and Forecasts
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Market Estimates and Forecasts, by Product, 2017 - 2030 (USD Million)
- 6.4.1.1. China Market Estimates and Forecasts
- 6.4.1.2. Japan Market Estimates and Forecasts
- 6.4.1.3. India Market Estimates and Forecasts
- 6.4.1.4. Australia Market Estimates and Forecasts
- 6.4.1.5. South Korea Market Estimates and Forecasts
- 6.5. Latin America
- 6.5.1. Latin America Market Estimates and Forecasts, by Product, 2017 - 2030 (USD Million)
- 6.5.1.1. Mexico Market Estimates and Forecasts
- 6.5.1.2. Brazil Market Estimates and Forecasts
- 6.5.1.3. Argentina Market Estimates and Forecasts
- 6.6. MEA
- 6.6.1. MEA Market Estimates and Forecasts, by Product, 2017 - 2030 (USD Million)
- 6.6.1.1. South Africa Market Estimates and Forecasts
- 6.6.1.2. Saudi Arabia Market Estimates and Forecasts
- 6.6.1.3. UAE Market Estimates and Forecasts
Chapter 7. Competitive Landscape
- 7.1 Competitive Dashboard Analysis
- 7.2 Public Companies
- 7.2.1 Company market position analysis
- 7.2.2 Heat Map Analysis
- 7.3 Detailed list of Market Players
Chapter 8. Company Profiles
- 8.1. IBM
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Strategic Initiatives
- 8.2. Cisco
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Strategic Initiatives
- 8.3. Given Imaging, Inc.
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Strategic Initiatives
- 8.4. Olympus Corporation
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Strategic Initiatives
- 8.5. Logi-Tag
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Strategic Initiatives
- 8.6. Brooks Automation
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Strategic Initiatives
- 8.7. Stanley Innerspace
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Strategic Initiatives
- 8.8. Solstice Medical LLC
- 8.8.1. Company Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Strategic Initiatives
- 8.9. GE Healthcare
- 8.9.1. Company Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Strategic Initiatives
- 8.10. Siemens Medical Solutions
- 8.10.1. Company Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Strategic Initiatives
- 8.11. McKesson Corp.
- 8.11.1. Company Overview
- 8.11.2. Financial Performance
- 8.11.3. Product Benchmarking
- 8.11.4. Strategic Initiatives
- 8.12. Allscripts Healthcare Solutions
- 8.12.1. Company Overview
- 8.12.2. Financial Performance
- 8.12.3. Product Benchmarking
- 8.12.4. Strategic Initiatives
- 8.13. Samsung Electronics Corporation
- 8.13.1. Company Overview
- 8.13.2. Financial Performance
- 8.13.3. Product Benchmarking
- 8.13.4. Strategic Initiatives
- 8.14. AirStrip Technologies Inc.
- 8.14.1. Company Overview
- 8.14.2. Financial Performance
- 8.14.3. Product Benchmarking
- 8.14.4. Strategic Initiatives
- 8.15. Apple Inc.
- 8.15.1. Company Overview
- 8.15.2. Financial Performance
- 8.15.3. Product Benchmarking
- 8.15.4. Strategic Initiatives
- 8.16. AT&T Inc.
- 8.16.1. Company Overview
- 8.16.2. Financial Performance
- 8.16.3. Product Benchmarking
- 8.16.4. Strategic Initiatives
- 8.17. Cerner Corporation
- 8.17.1. Company Overview
- 8.17.2. Financial Performance
- 8.17.3. Product Benchmarking
- 8.17.4. Strategic Initiatives
- 8.18. Pepperl+Fuchs
- 8.18.1. Company Overview
- 8.18.2. Financial Performance
- 8.18.3. Product Benchmarking
- 8.18.4. Strategic Initiatives
- 8.19. Hurst Green Plastics Ltd.
- 8.19.1. Company Overview
- 8.19.2. Financial Performance
- 8.19.3. Product Benchmarking
- 8.19.4. Strategic Initiatives
- 8.20. Bollhoff Group
- 8.20.1. Company Overview
- 8.20.2. Financial Performance
- 8.20.3. Product Benchmarking
- 8.20.4. Strategic Initiatives
- 8.21. Wurth Group
- 8.21.1. Company Overview
- 8.21.2. Financial Performance
- 8.21.3. Product Benchmarking
- 8.21.4. Strategic Initiatives
- 8.22. Brooks Automation
- 8.22.1. Company Overview
- 8.22.2. Financial Performance
- 8.22.3. Product Benchmarking
- 8.22.4. Strategic Initiatives
- 8.23. LogTag
- 8.23.1. Company Overview
- 8.23.2. Financial Performance
- 8.23.3. Product Benchmarking
- 8.23.4. Strategic Initiatives
- 8.24. Stanley Innerspace
- 8.24.1. Company Overview
- 8.24.2. Financial Performance
- 8.24.3. Product Benchmarking
- 8.24.4. Strategic Initiatives